[HTML][HTML] FDG PET/CT for assessing tumour response to immunotherapy: Report on the EANM symposium on immune modulation and recent review of the literature
N Aide, RJ Hicks, C Le Tourneau, S Lheureux… - European journal of …, 2019 - Springer
This paper follows the immunotherapy symposium held during the European Association of
Nuclear Medicine (EANM) 2017 Annual Congress. The biological basis of the immune …
Nuclear Medicine (EANM) 2017 Annual Congress. The biological basis of the immune …
18F FDG PET/CT and Novel Molecular Imaging for Directing Immunotherapy in Cancer
DJ Hughes, M Subesinghe, B Taylor, A Bille, J Spicer… - Radiology, 2022 - pubs.rsna.org
Immunotherapy has transformed the treatment landscape of many cancers, with durable
responses in disease previously associated with a poor prognosis. Patient selection remains …
responses in disease previously associated with a poor prognosis. Patient selection remains …
[HTML][HTML] KPNB1-mediated nuclear translocation of PD-L1 promotes non-small cell lung cancer cell proliferation via the Gas6/MerTK signaling pathway
W Du, J Zhu, Y Zeng, T Liu, Y Zhang, T Cai… - Cell Death & …, 2021 - nature.com
In addition to the role of programmed cell death ligand 1 (PD-L1) in facilitating tumour cells
escape from immune surveillance, it is considered as a crucial effector in transducing …
escape from immune surveillance, it is considered as a crucial effector in transducing …
[HTML][HTML] Comprehensive analysis of the association between tumor glycolysis and immune/inflammation function in breast cancer
W Li, M Xu, Y Li, Z Huang, J Zhou, Q Zhao, K Le… - Journal of translational …, 2020 - Springer
Background Metabolic reprogramming, immune evasion and tumor-promoting inflammation
are three hallmarks of cancer that provide new perspectives for understanding the biology of …
are three hallmarks of cancer that provide new perspectives for understanding the biology of …
[HTML][HTML] The efficiency of 18F-FDG PET-CT for predicting the major pathologic response to the neoadjuvant PD-1 blockade in resectable non-small cell lung cancer
X Tao, N Li, N Wu, J He, J Ying, S Gao, S Wang… - European journal of …, 2020 - Springer
Abstract Purpose Investigate whether 18 F-FDG PET-CT has the potential to predict the
major pathologic response (MPR) to neoadjuvant sintilimab in resectable NSCLC patients …
major pathologic response (MPR) to neoadjuvant sintilimab in resectable NSCLC patients …
Immuno-PET imaging of 68Ga-labeled nanobody Nb109 for dynamic monitoring the PD-L1 expression in cancers
Q Liu, L Jiang, K Li, H Li, G Lv, J Lin, L Qiu - Cancer Immunology …, 2021 - Springer
The checkpoint blockade immunotherapy has become a potent treatment strategy for
cancers, and programmed death ligand-1 (PD-L1) is a prominent checkpoint ligand that is …
cancers, and programmed death ligand-1 (PD-L1) is a prominent checkpoint ligand that is …
18F-FDG PET/CT in non-small-cell lung cancer patients: a potential predictive biomarker of response to immunotherapy
L Evangelista, L Cuppari, J Menis… - Nuclear Medicine …, 2019 - journals.lww.com
Aim The aim of this study was to assess the predictive role of fluorine-18-fluorodeoxyglucose
(18 F-FDG) PET/computed tomography (CT) in the evaluation of response to immunotherapy …
(18 F-FDG) PET/computed tomography (CT) in the evaluation of response to immunotherapy …
[HTML][HTML] 2-Deoxy-2-[fluorine-18] fluoro-d-glucose uptake on positron emission tomography is associated with programmed death ligand-1 expression in patients with …
K Kaira, K Shimizu, S Kitahara, T Yajima… - European Journal of …, 2018 - Elsevier
Deoxy-2-[fluorine-18] fluoro-d-glucose (18 F-FDG) positron emission tomography (PET) is a
useful modality for the assessment of tumour glucose metabolism by upregulation by …
useful modality for the assessment of tumour glucose metabolism by upregulation by …
The “digital biopsy” in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F] FDG PET/CT
L Monaco, E De Bernardi, F Bono, D Cortinovis… - European Journal of …, 2022 - Springer
Purpose The present pilot study investigates the putative role of radiomics from [18F] FDG
PET/CT scans to predict PD-L1 expression status in non-small cell lung cancer (NSCLC) …
PET/CT scans to predict PD-L1 expression status in non-small cell lung cancer (NSCLC) …
[HTML][HTML] Potential of FDG-PET as prognostic significance after anti-PD-1 antibody against patients with previously treated non-small cell lung cancer
K Hashimoto, K Kaira, O Yamaguchi, A Mouri… - Journal of Clinical …, 2020 - mdpi.com
It remains unclear whether the accumulation of 2-deoxy-2-[18F] fluoro-d-glucose (18F-FDG)
before the initiation of anti-programmed death-1 (PD-1) antibody can predict the outcome …
before the initiation of anti-programmed death-1 (PD-1) antibody can predict the outcome …